SCHEMBL6445922

SCHEMBL6445922

CC(C)C(NC(=O)OCc1ccccn1)C(=O)O.[LiH]

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.58
RAB9A P51151 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
LMNA P02545 1/20 0.58
ADAMTS4 O75173 1/20 0.53
MAPT P10636 1/20 0.47
PGR P06401 1/20 0.47
ADORA3 P0DMS8 1/20 0.47
PTGS1 P23219 1/20 0.47
SLC6A2 P23975 1/20 0.47
ELANE P08246 2/20 0.47
TYR P14679 1/20 0.46
ECE1 P42892 2/20 0.44
MME P08473 1/20 0.44
ALDH1A1 P00352 3/20 0.44
CTSL P07711 1/20 0.44
CTSB P07858 1/20 0.44
CTSS P25774 1/20 0.44
CTSK P43235 1/20 0.44
PTPRA P18433 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6445930 1.00 NPC1 (0.58) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL3033874 0.99 NPC1 (0.59) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL4675990 0.99 NPC1 (0.59) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL3029779 0.88 NPC1 (0.56) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL4680818 0.88 NPC1 (0.56) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL7310548 0.88 RAB9A (0.55) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL7310554 0.88 RAB9A (0.55) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
Lithium Ion SCHEMBL6445927 0.86 SMN1; SMN2 (0.53) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL6841163 0.84 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2LMNAADAMTS4
SCHEMBL6841164 0.84 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2LMNAADAMTS4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0839798-B1 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LAB (US) 2005-08-17 EP disclosed
EP-0402646-B1 Retroviral protease inhibiting compounds ABBOTT LAB (US) 1998-07-22 EP disclosed
EP-0839798-A2 Intermediates for preparating non-peptide retroviral protease inhibitors ABBOTT LABORATORIES (US) 1998-05-06 EP disclosed
US-5545750-A TREATING HUMAN IMMUNODEFICIENCY VIRUS ABBOTT LABORATORIES (US) 1996-08-13 US disclosed
US-5142056-A Human immunodeficiency virus protease inhibitor ABBOTT LABORATORIES (US) 1992-08-25 US disclosed
EP-0402646-A1 Retroviral protease inhibiting compounds ABBOTT LABORATORIES (US) 1990-12-19 EP disclosed